BETA 2 GLYCOPROTEIN 1 PANEL IgG IgM and IgA Test
Cost: AED 610.0
Test Components
- Price: 610.0 AED
- Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
- Report Delivery: Sample Mon / Thu by 9 am; Report Same day
- Method: Enzyme Immunoassay
- Test type: Thromboembolic disorders
- Doctor: Physician, Gynecologist
- Test Department:
Pre Test Information
No special preparation required
Test Details
The BETA 2 GLYCOPROTEIN 1 PANEL IgG IgM & IgA test is a blood test used to detect antibodies against beta-2 glycoprotein 1 (2GP1) in the body. 2GP1 is a protein that plays a role in the clotting process and is associated with autoimmune disorders, particularly antiphospholipid syndrome (APS).
Antiphospholipid syndrome is an autoimmune disorder where the body mistakenly produces antibodies against its own cells, including 2GP1. These antibodies can lead to excessive blood clotting, miscarriages, and other complications.
The BETA 2 GLYCOPROTEIN 1 PANEL IgG IgM & IgA test measures the levels of three types of antibodies: IgG, IgM, and IgA, against 2GP1. The presence of these antibodies can help diagnose APS or monitor the effectiveness of treatment.
It is important to note that this test alone is not sufficient to diagnose APS. It is usually used in conjunction with other clinical findings and tests, such as the lupus anticoagulant test and anticardiolipin antibody test, to confirm the diagnosis.
The BETA 2 GLYCOPROTEIN 1 PANEL IgG IgM & IgA test is typically performed on individuals who have a history of blood clots, recurrent miscarriages, or unexplained symptoms suggestive of APS. It may also be ordered to monitor the response to treatment in individuals with APS.
The test involves taking a blood sample from a vein in the arm. The sample is then sent to a laboratory for analysis. Results are usually reported as positive or negative for each antibody type.
It is important to consult with a healthcare provider to interpret the results of this test and determine the appropriate course of action.
Test Name | BETA 2 GLYCOPROTEIN 1 PANEL IgG IgM and IgA Test |
---|---|
Components | |
Price | 610.0 AED |
Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
Report Delivery | SampleMon / Thu by 9 am; Report Same day |
Method | Enzyme Immunoassay |
Test type | Thromboembolic disorders |
Doctor | Physician, Gynecologist |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details |
The BETA 2 GLYCOPROTEIN 1 PANEL IgG IgM & IgA test is a blood test used to detect antibodies against beta-2 glycoprotein 1 (2GP1) in the body. 2GP1 is a protein that plays a role in the clotting process and is associated with autoimmune disorders, particularly antiphospholipid syndrome (APS). Antiphospholipid syndrome is an autoimmune disorder where the body mistakenly produces antibodies against its own cells, including 2GP1. These antibodies can lead to excessive blood clotting, miscarriages, and other complications. The BETA 2 GLYCOPROTEIN 1 PANEL IgG IgM & IgA test measures the levels of three types of antibodies: IgG, IgM, and IgA, against 2GP1. The presence of these antibodies can help diagnose APS or monitor the effectiveness of treatment. It is important to note that this test alone is not sufficient to diagnose APS. It is usually used in conjunction with other clinical findings and tests, such as the lupus anticoagulant test and anticardiolipin antibody test, to confirm the diagnosis. The BETA 2 GLYCOPROTEIN 1 PANEL IgG IgM & IgA test is typically performed on individuals who have a history of blood clots, recurrent miscarriages, or unexplained symptoms suggestive of APS. It may also be ordered to monitor the response to treatment in individuals with APS. The test involves taking a blood sample from a vein in the arm. The sample is then sent to a laboratory for analysis. Results are usually reported as positive or negative for each antibody type. It is important to consult with a healthcare provider to interpret the results of this test and determine the appropriate course of action. |